Sentence examples for remission ratio from inspiring English sources

In this regard, the difference in the number and characteristics of the enrolled patients may account for the differences in the clinical remission ratio between the present study and previous data.

In addition, Baert et al. [ 18] demonstrated the importance of mucosal healing defined as SES-CD 0, based on a significant difference in the steroid-free remission ratio after therapy between patients with CD with SES-CD 0 and SES-CD 1 9.

We also calculated pooled remission rate ratio and 95% CI.

Participants receiving internet-based interventions were also more likely than waitlist controls to be free of a diagnosis of anxiety disorder after the treatment (remission rate ratio and 95% CI = 3.63 [1.59, 8.27], p for heterogeneity test = 0.87, I = 0%), Figure  2(b).

Similar as previously reported, the SE-alleles associated with less remission (hazard ratio (HR) = 0.57, 95%% confidence interval (95%% CI) = 0.42-0.77, p = 2.72×10−4).

It was found that Triptolide indeed resulted in a significant increase of complete remission (odds ratio (OR) 2.81, 95% CI 1.26 to 6.30) and total remission (OR 3.25, 95% CI 1.20 to 8.76) compared with cyclophosphamide or placebo.

Non-remitted patients showed a significantly higher risk of having suicidal thoughts during the past month than those in remission (odds ratio [OR] 2.55; 95% confidence interval [CI], 1.50 4.33; p = 0.0006).

Moreover, TCZ patients were five times more likely to achieve DAS28 remission (odds ratio versus MTX: 5.83; 95% confidence interval [CI] 3.27 to 10.40), and approximately four times more likely to achieve at least a moderate EULAR response (odds ratio versus MTX: 4.24, 95% CI 2.92 to 6.14).

By week 24, tocilizumab patients were five times more likely to achieve DAS28 remission (odds ratio vs methotrexate: 5.83; 95% CI 3.27 to 10.40), and approximately four times more likely to achieve at least a moderate EULAR response (odds ratio vs methotrexate: 4.24, 95% CI 2.92 to 6.14; fig 2D).

Multivariate analysis with a binary logistic regression model showed that treatment duration was an independent determinant of sustained virologic remission (odds ratio = 64.2, p = 0.042; Table  2).> Of 79 patients with off-treatment virologic relapse, one patient was lost to follow up and 13 patients were followed without further antiviral therapy.

In multivariate analysis incomplete surgical remission (hazard ratio (HR) 4.48, 95% CI: 3.08 6.52), metastases at presentation (HR 2.93, 95% CI: 1.95 4.41), microscopic tumour necrosis (HR 1.88, 95% CI: 1.27 2.78) and central tumour site (HR 1.71, 95% CI: 1.18 2.47) remained significant adverse prognostic factors, but not sarcoma category (RIS vs sporadic).